NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NOL - NOBLEOAK LIFE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.60

21 Nov
2024

-0.020

OPEN

$1.60

-1.23%

HIGH

$1.60

675

LOW

$1.60

TARGET
$2.85 78.1% upside
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NOL: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 10.8 19.2 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx 15.6% 78.4% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 8.6 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx10.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx386.6 M
Book Value Per Share xxxxxxxxxxxxxxx82.7
Net Operating Cash Flow xxxxxxxxxxxxxxx44.4 M
Net Profit Margin xxxxxxxxxxxxxxx2.40 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx9.71 %
Return on Invested Capital xxxxxxxxxxxxxxx9.23 %
Return on Assets xxxxxxxxxxxxxxx2.60 %
Return on Equity xxxxxxxxxxxxxxx9.71 %
Return on Total Capital xxxxxxxxxxxxxxx13.38 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx44.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx5 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx0 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx64 M
Price To Book Value xxxxxxxxxxxxxxx1.74

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx0.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.10 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx76 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx208 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

02/10/2024

1

Buy, High Risk

$2.85

78.13%

In a strategic move to streamline costs, NobleOak Life will essentially buy back trail commissions at less than 100 cents in the dollar while still providing access to 480,000 potential customers, explains Shaw and Partners.

The company has struck a conditional sale agreement with RevTech Media Pty Ltd.

Trail commissions are ongoing payments made to financial advisors for the duration of a policy.

Management revealed the acquisition will be value accretive, exceeding the company's investment hurdles, and generating free annual cash flow over an extended period as the portfolio eventually winds down.

Buy, High Risk rating retained. Target is steady at $2.85.

FORECAST
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 19.20 cents.
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.50 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

NOL STOCK CHART

FNArena News on NOL

1
FNArena Corporate Results Monitor – 02-09-2024

Sep 02 2024 - Australia
2
Next Week At A Glance – 22-26 July 2024

Jul 19 2024 - Weekly Reports
3
FNArena Corporate Results Monitor – 29-02-2024

Feb 29 2024 - Australia
4
Rudi’s Views: August 2023 – Winners & Losers

Sep 13 2023 - Rudi's View
5
FNArena Corporate Results Monitor – 01-09-2023

Sep 01 2023 - Australia

Latest Insurance News

1
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
2
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
3
Steadfast’s Long March

Jul 02 2024 - Australia
4
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
5
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
6
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
7
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
8
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia
9
Underlying Trends Positive For QBE Insurance

May 15 2023 - Australia
10
Rates Over Reinsurance For General Insurers 

Feb 01 2023 - Australia